Nanomedicine applications in the treatment of breast cancer: current state of the art
Di Wu, Mengjie Si, Hui-Yi Xue, Ho-Lun Wong Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA Abstract: Breast cancer is the most common malignant disease in women worldwide, but the current drug therapy is far from optimal as indicated by the high d...
Guardado en:
Autores principales: | Wu D, Si M, Xue H, Wong HL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2782023edd084843a48ad324a8e2dccd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models
por: Sayoni Maitra Roy, et al.
Publicado: (2021) -
Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine?
por: Maylis Garnier, et al.
Publicado: (2021) -
Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System
por: Jinxiu Li, et al.
Publicado: (2021) -
Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy
por: Huan Zhang, et al.
Publicado: (2021) -
Commercial utilities and future perspective of nanomedicines
por: Rishabha Malviya, et al.
Publicado: (2021)